42 healthy persons and 52 diabetic patients were measured to clarify the blood HbA1c and serum glucose level simultaneously, using low pressure cation exchange chromatography and colormetric enzyme method. The results: the mean value of blood HbA1c is 5.130.53% (4.1-6.2%). The mean value of blood HbA1c in diabetic patients are higher than that of normal persons; the fluctuate from 5.9 to 12.5%. Positive correlation between blood HbA1c and serum plucose in normal persons has been indicated in the investigated subjects, characterized by the following equation: Y = 0.39 X +3.01; r=0.3632. These correlation in diabetic patients has been indicated and characterized by the following equation: Y =0.98 X + 1.99; r=+0.5891 (in which: X= blood HbA1c , Y = serum glucose level)
Diabetes Mellitus ; Serum ; Blood

Investigation on 72 diabetics in Ha Noi communities found that: Lipaemia disorders of diabetics were high. Among cholesterol total (CT) increased acquired 41.67%, trigleceride (TG) increased acquired 38.89%, high density lipid (HDLC) decreased acquired 26.39% and low density lipid (LDLC) increased acquired 25%. The disorders associated 2 lipid index commonly was: CT increased associated with LDLC increased, then CT increased associated with TG increased and CT increased associated with high density lipid HDLC decreased. The complications indiabetics with lipeamia disorders such as: hypertension, visual acuity decreased, retinopathy and peripheral neural lesions
Diabetes Mellitus ; lipids ; blood

No abstract available.
Biomarkers* ; Blood Platelets* ; Diabetes Mellitus*

No abstract available.
Biomarkers* ; Blood Platelets* ; Diabetes Mellitus*

From Jan 1992 to Jan 2001, at the Hospital N0198, 405 diabetes patients aged 17-73 were studied. Results showed a rate of high blood pressure of 19% among diabetes patients, this rate was similar in male as in female gender. The most common age was 50-59 year old age, which accounted for 31.8%. Among patients with diabetes of type 1, the rate accounted for 19.4%, type 2 18.8%. The rate of kidney complications of diabetes patients with high blood pressure was 33.9%, while without high blood pressure ones was 11.3%. The rate of eyefundus complications was 33.9% and 9.2% respectively
Hypertension ; Diabetes Mellitus ; Blood Pressure

BACKGROUND: Glucometers are widely used for self-monitoring and point-of-care testing in diabetes management. We evaluated the performance of the recently developed Wisecheck Glucose Monitoring System (Wisemeditech, Korea) compared to that of 2 other well-known glucometer systems. METHODS: The Wisecheck glucometer was evaluated for precision, linearity, and carryover rate. One-hundred fifty samples samples were tested, and the results obtained from the Wisecheck glucometer, ACCU-CHEK Performa (Roche Diagnostics, Germany) and SD GlucoLink (SD Diagnostics, Korea) were compared to those obtained using the laboratory reference method from the Toshiba 200FR (Toshiba, Japan), according to the Clinical and Laboratory Standards Institute (CLSI) guidelines. RESULTS: The coefficient of variation (CV) values for within-run imprecision at low, middle, and high levels were 2.06%, 1.02%, and 2.02%, respectively, and the CV values for total-run imprecision at low, middle, and high levels were 2.98%, 2.41%, and 1.88%, respectively. In the linearity test, the coefficient of determination (R2) was 0.9985 in glucose concentration ranging from 48.6 mg/dL to 428 mg/dL (P<0.0001). The results obtained using the Wisecheck glucometer were well correlated with those obtained using the Toshiba 200FR (R2=0.980, P<0.0001). The carryover rate was 0.12%. CONCLUSIONS: The Wisecheck glucometer showed good precision, linearity, and correlation with the reference method. It provided rapid and reliable measurements of blood glucose levels and seemed appropriate for use in diabetes management.
Blood Glucose ; Diabetes Mellitus ; Glucose* ; Methods

BACKGROUND: Self-monitoring blood glucose devices are widely used for self-monitoring and point-of-care testing (POCT) in the management of diabetic patients. We performed the present study to evaluate the performance of Precision Q.I.DR Blood Glucose Testing System using electochemical detection techique. METHODS: Precision Q.I.DR was evaluated for linearity, precision, comparison of method, and the effect of sample volume, hematocrit concentration, reapplication, operator, and application methods. RESULTS: Precision Q.I.DR revealed good linearity in glucose concentration ranging from 40 mg/dL to 550 mg/dL (r2=0.9874). In the precision study, within-run and total-run CVs were within 10%. Excellent correlation was found between Precision Q.I.DR and Hitachi 7070 (y = 1.0332 x, r = 0.9195). Sample volume, reapplication, operator, and application method did not produce significant effect on the test result. Over- or underestimation of glucose values was found with the change of hematocrit concentration. CONCLUSIONS: Precision Q.I.DR showed good linearity, precision, and correlation with reference method. No significant effect of testing procedure or operator was found. Precision Q.I.DR provided rapid and reliable result of blood glucose and seems appropriate for clinical use in the management of diabetic patients.
Blood Glucose ; Diabetes Mellitus ; Glucose* ; Hematocrit ; Humans

BACKGROUND: Self-monitoring devices for blood glucose are widely used as a point-of-care testing (POCT) in the management of diabetic patients. In the present study, we evaluated the performance of SD CHECK GOLD Blood Glucose Testing System (SD diagnostic, Korea) using electrochemical detection technique. METHODS: SD CHECK GOLD was tested for linearity, precision and comparison of method. Other glucometers including ACCU CHEK ACTIVE (Roche Diagnostics Ltd., Germany) and ONE TOUCH ULTRA (Lifescan Inc., USA) were compared for the same categories according to the Clinical and Laboratory Standards Institute (CLSI) guidelines. RESULTS: SD CHECK GOLD revealed good linearity in glucose concentration ranging from 50 mg/dL to 550 mg/dL (r(2)=0.9931). In the precision study, within-run precision and total-run precision (CV)s were within 10%. Excellent correlation was found between SD CHECK GOLD and Toshiba 200FR (Toshiba, Japan) (y=0.9212x, r=0.9756). CONCLUSIONS: SD CHECK GOLD showed good linearity, precision, and correlation with the reference method. No significant effect of testing procedure or operator was found. SD CHECK GOLD provided rapid and reliable results for blood glucose and seemed to be appropriate for the clinical useful in the management of diabetic patients.
Blood Glucose ; Diabetes Mellitus ; Glucose ; Humans

37 diabetes patients (21 male and 16 female) tested peripheral blood to investigate on quantity of cholesterol, glucose and triglyceride. The results showed that the number of diabetic peoples are ranged from 40 to 70 years old. In which, highest diabetic people ratio are ranged from 40 to 50 years old and male patient ratio are higher than female. Quantity of serum glucose, cholesterol and triglyceride all increased
Diabetes Mellitus ; aged ; Cholesterol ; glucose ; Triglycerides ; Blood

The diabetic patients are usually suffered from oxidation stress. Green tea is one of the good herbal medicines has been used for treatment of some diseases. Objectives: Evaluate change of antioxidant status in blood and effect of the green tea polyphenol on this change in the experimental diabetic rats. Methods: Using in vivo model to investigate some biological indicators in STZ - induced diabetic rats fed with high fat diet and to evaluate effect of the green tea polyphenol on the changes of these indicators. Results: Erythrocyte GPx activity and serum MDA concentration in STZ - induced diabetic rats was higher than that of normal and lipid metabolism disorder groups (p < 0.001) and effected of the green tea polyphenol. However, no change in erythrocyte SOD activity and plasma TAS level was observed. Conclusions: Green tea polyphenol improved blood antioxidant status in STZ - induced diabetic rats.
Diabetes Mellitus ; Tea ; Camellia sinensis ; Blood ; Oxidants